Skip to content

Study · Randomized controlled trial · n = 20 · 1996

1 result

Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis.

Filicori M, Flamigni C, Cognigni GE, Falbo A, Arnone R, Capelli M, Pavani A, Mandini M, Calderoni P, Brondelli L

Fertility and sterility1 Feb 1996Cited by 24 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In eumenorrheic women, purified FSH with flare-up leuprorelin produced fewer preovulatory follicles than purified FSH with long leuprorelin.

    In plain wordsIn eumenorrheic women, flare-up leuprorelin produced fewer preovulatory follicles than long leuprorelin with the same FSH background.

    Peptide
    Leuprolide
    Outcome
    DecreasePreovulatory follicles
    Study

    n = 20

    Comparator
    Purified FSH with long GnRH agonist regimen
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Group B had fewer preovulatory follicles than group C.
    3 context sentences
    Title · context
    Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis.
    Summary · context
    Forty eumenorrheic women randomly assigned to four groups of 10 subjects each.
    Summary · context
    Ovulation induction regimens: group A, purified FSH only; group B, purified FSH and flare-up GnRH-a; group C, purified FSH and long GnRH-a; and group D, hMG and long GnRH-a.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:37 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.